Bone Biologics Ratios (2016-2017) | BBLG

Ratios Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017
Profitability
EBT Margin 3,954.41%1,304.78%1,165.10%383.36%-106.36%190.83%189.83%
EBIT Margin 2,936.14%1,204.78%1,065.10%283.36%-206.36%90.83%89.83%
EBITDA Margin 2,936.14%1,204.78%1,065.10%283.36%-206.36%90.83%89.83%
Operating Margin 2,936.14%1,204.78%1,065.10%283.36%-206.36%90.83%89.83%
Net Margin 3,954.93%1,304.78%1,165.37%383.36%-106.19%190.83%189.83%
FCF Margin 814.94%563.16%415.86%132.23%86.65%45.06%63.86%
Efficiency
Assets Average 3.33M1.55M0.74M1.20M1.28M1.27M
Equity Average -4.30M-6.17M-7.66M-8.11M-8.76M-9.93M
Invested Capital -3.23M-5.38M2.04M-7.16M4.35M2.52M2.72M
Asset Utilization Ratio -1.40-1.24-1.62-2.34
Leverage & Solvency
Interest Coverage Ratio -29.36-12.05-10.65-2.832.06-0.91-0.90
Debt to Equity -2.15-1.05-2.40-1.97-1.97
Debt Ratio 19.4012.5011.0921.9812.05
Equity Ratio -0.75-2.30-9.02-11.93-4.63-11.14-6.10
Times Interest Earned -29.36-12.05-10.65-2.832.06-0.91-0.90
Valuation
Enterprise Value -4.22M-2.19M-0.69M-0.62M-1.61M-0.78M-1.62M
Return Ratios
Return on Sales 39.55%13.05%11.65%25.07%3.83%-1.06%1.91%1.90%
Return on Capital Employed 26.66%21.87%5.11%1.74%
Return on Invested Capital 7.97%-2.08%-1.69%
Return on Assets -35.15%-13.80%-8.44%-7.08%
Return on Equity 3.38%2.04%1.24%0.90%